Literature DB >> 29269786

Peripheral neuropathies: Antisense therapy for Charcot-Marie-Tooth disease?

Charlotte Ridler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29269786     DOI： 10.1038/nrneurol.2017.182

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

1.  PMP22 antisense oligonucleotides reverse Charcot-Marie-Tooth disease type 1A features in rodent models.

Authors:  Hien Tran Zhao; Sagar Damle; Karli Ikeda-Lee; Steven Kuntz; Jian Li; Apoorva Mohan; Aneeza Kim; Gene Hung; Mark A Scheideler; Steven S Scherer; John Svaren; Eric E Swayze; Holly B Kordasiewicz
Journal:  J Clin Invest       Date:  2017-12-04       Impact factor: 14.808
  1 in total
  1 in total

Review 1.  Current profile of Charcot-Marie-Tooth disease in Africa: A systematic review.

Authors:  Abdoulaye Yalcouyé; Kevin Esoh; Landouré Guida; Ambroise Wonkam
Journal:  J Peripher Nerv Syst       Date:  2022-04-05       Impact factor: 5.188
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.